Admission Date:  [**2107-12-29**]              Discharge Date:   [**2108-1-7**]

Date of Birth:  [**2038-7-5**]             Sex:   F

Service: CARDIOTHORACIC

Allergies:
Lisinopril

Attending:[**First Name3 (LF) 1267**]
Chief Complaint:
worsening fatigue with CHF and a positive ETT

Major Surgical or Invasive Procedure:
cabg x3/ LAD endarterectomy (LIMA to LAD, SVG to OM, SVG to
PDA)and placement of Biventricular pacing leads on [**2107-12-29**]


History of Present Illness:
65 yo African-American female with worsening fatigue. Had an
admission in [**Month (only) **]. for CHF and workup revealed a depressed EF and
some wall motion abnormalities. She was referred to [**Hospital1 18**] for
cath and evaulation. She underwent cath in [**Month (only) **]. which showed LAD
100%, 100% Diag 1, CX 100%, 70% OM1, 100% RCA. Referred to Dr.
[**Last Name (STitle) **] for CABG.

Past Medical History:
NIDDM with triopathy
obesity
HTN
CHF
CRI (baseline approx. 1.3)
Asthma as a child.
History of recurrent angioedema secondary to medications
including ACE inhibitor.
Coronary artery disease
inferior MI ( unknown date)

Social History:
divorced, lives alone
has great difficulty [**Location (un) 1131**]

Family History:
sister had MI at age 60

Physical Exam:
5'2" 190 pounds
156/96  HR 69   sat 100% 2L NC  RR 16
Pupils equal, constricted and mildly reactive, NCAT,
no thyromegaly or JVD, no carotid bruits
RRR no m/r/g
CTAB
obese abd, soft, NT, ND with positive BS
extrems no c/c/e
pulses 2+ bil carotid /brachial/ radial/PT;  2+ right fem, left
dressing

Pertinent Results:
[**2108-1-3**] 01:44AM BLOOD WBC-15.3* RBC-3.49* Hgb-10.4* Hct-31.2*
MCV-89 MCH-29.7 MCHC-33.3 RDW-14.8 Plt Ct-129*
[**2108-1-3**] 01:44AM BLOOD Plt Ct-129*
[**2108-1-2**] 04:00AM BLOOD PT-14.4* PTT-26.7 INR(PT)-1.4
[**2108-1-3**] 01:44AM BLOOD Glucose-71 UreaN-38* Creat-1.1 Na-139
K-4.3 Cl-106 HCO3-23 AnGap-14
[**2108-1-1**] 11:41AM BLOOD ALT-3 AST-29 LD(LDH)-351* AlkPhos-67
Amylase-35 TotBili-0.3
[**2108-1-1**] 11:41AM BLOOD Lipase-16
[**2108-1-3**] 01:44AM BLOOD Calcium-8.8 Phos-3.1# Mg-2.2
[**2108-1-7**] 04:44AM BLOOD WBC-11.1* RBC-3.05* Hgb-9.5* Hct-27.9*
MCV-91 MCH-31.1 MCHC-34.1 RDW-14.6 Plt Ct-232
[**2108-1-7**] 04:44AM BLOOD Plt Ct-232
[**2108-1-7**] 04:44AM BLOOD Glucose-76 UreaN-41* Creat-1.5* Na-145
K-5.0 Cl-108 HCO3-27 AnGap-15
[**2108-1-1**] 11:41AM BLOOD ALT-3 AST-29 LD(LDH)-351* AlkPhos-67
Amylase-35 TotBili-0.3
[**2108-1-7**] 04:44AM BLOOD Mg-2.1

Brief Hospital Course:
Admitted on [**12-29**] and underwent CABG x3 /LAD endarterectomy /
placement of biventricular leads with Dr. [**Last Name (STitle) **]. Transferred to
the CSRU in stable condition. Required minimal inotropic support
for 72hrs and weaned off successfully. Extubated on POD #1.
Marginal urine output and rising creatinine to maximum 2.3 and
settled over the next few days to baseline levels.Transferred to
the floor on POD #5 and pacing wires were removed. PICC access
needed and obtained. UTI post op and was started on
Ciprofloxacin on day 8. [**Last Name (un) **] consult was obtained for glucose
management. She had continuing peripheral edema and continued on
IV lasix. She needed additional PT/ monitoring and was
transferred to rehab on POD # 9 in good condition.

Medications on Admission:
diovan
aldactone
lipitor
toprol XL
lasix 40 mg daily
norvasc
imdur
metformin
celexa
aspirin
avandia

Discharge Medications:
1. Metoprolol Tartrate 25 mg Tablet Sig: Three (3) Tablet PO BID
(2 times a day).
2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
3. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1)
Tablet, Delayed Release (E.C.) PO DAILY (Daily).
4. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every
4 hours) as needed.
5. Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO
Q4H (every 4 hours) as needed for pain.
6. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30)
ML PO HS (at bedtime) as needed for constipation.
7. Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal
DAILY (Daily) as needed for constipation.
8. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
9. Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
10. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).
11. Hydralazine 25 mg Tablet Sig: One (1) Tablet PO Q6H (every 6
hours) as needed for SBP>160.
12. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).

13. Potassium Chloride 10 mEq Capsule, Sustained Release Sig:
Two (2) Capsule, Sustained Release PO BID (2 times a day).
14. Citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
15. Glyburide 5 mg Tablet Sig: Two (2) Tablet PO BID (2 times a
day).
16. Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H
(every 24 hours) for 7 days.
17. Furosemide 10 mg/mL Solution Sig: Two (2)  Injection [**Hospital1 **] (2
times a day).


Discharge Disposition:
Extended Care

Facility:
[**Location (un) 11729**] Home - [**Location (un) 686**]

Discharge Diagnosis:
s/p cabg x 3/ LAD endarterectomy/ placement of biventricular
leads
obesity
elev. chol.
HTN
NIDDM
CRI
CHF
PICC line placement


Discharge Condition:
stable


Discharge Instructions:
no lotions, creams or powders on anyh incision
may shower over incisions and pat dry
no lifting greater than 10 pounds for 10 weeks
no driving for one month

Followup Instructions:
follow up with Dr. [**Last Name (STitle) **] in [**1-23**] weeks
follow up with Dr. [**Last Name (STitle) **] in [**2-24**] weeks
See Dr. [**Last Name (STitle) **] for postop surgical visit in 4 weeks [**Telephone/Fax (1) 170**]



Completed by:[**2108-1-19**]